| Financial Year |
March 31 2023 |
| Monetary Funds |
4,418,876,778.94 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
76,021,250.67 |
| Accounts Receivable |
7,179,184,365.56 |
| Advances to Suppliers |
485,686,987.48 |
| Other Receivables |
245,245,449.39 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
5,152,966,719.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
498,074,043.47 |
| Total Current Assets |
19,110,519,862.05 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
432,637,987.86 |
| Investment Properties |
-- |
| Fixed Assetes |
2,517,849,551.49 |
| Under-construction Projects |
985,106,558.74 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
187,462,193.37 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,632,600.60 |
| Deferred Income Tax Assets |
549,096,280.55 |
| Other Non-Current Assets |
3,529,598,808.92 |
| Sub-Total of Non-Current Assets |
8,479,113,399.65 |
| Total Assets |
27,589,633,261.70 |
| Short-Term Loans |
685,309,919.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
7,606,037,949.51 |
| Accounts Payable |
6,648,991,215.35 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
51,359,691.70 |
| Taxes Payable |
117,664,382.36 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
428,844,329.84 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
149,092,458.92 |
| Other Current Liabilities |
571,160,073.35 |
| Sub-Total of Current Liabilities |
18,895,919,685.08 |
| Long-term Loans |
1,046,366,980.96 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
249,168,593.25 |
| Special Payable |
-- |
| Estimatied Liabilities |
2,015,099,912.82 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,631,184,614.88 |
| Total Liabilities |
22,527,104,299.96 |
| Paid-In Capital(Or Share Stock) |
702,078,355.00 |
| Capital Surplus |
2,419,447,560.31 |
| Surplus Reserve |
166,152,208.67 |
| LESS:Treasury Stock |
61,326,400.00 |
| Undistributed Profits |
1,684,851,584.75 |
| Minority Stockholder's Interest |
122,064,438.58 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,940,464,523.16 |
| Owner's Equity（Stockholder's Equity） |
5,062,528,961.74 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
27,589,633,261.70 |
